CAMBRIDGE, ON, May 19, 2022
/CNW/ - ATS Automation Tooling Systems Inc. (TSX: ATA) ("ATS" or
the "Company") today reported its financial results for the three
and twelve months ended March 31,
2022.
Fourth quarter highlights:
- Revenues increased 50.8% year over year to $603.2 million.
- Net income increased 67.6% year over year to $39.9 million.
- Earnings per share were 43 cents
basic and diluted compared to 26
cents a year ago.
- Adjusted basic earnings per share1 were 64 cents compared to 34
cents a year ago.
- Order Bookings1 were $638
million, 37.8% higher compared to $463 million a year ago.
- Order Backlog1 increased 24.0% to $1,438 million at March
31, 2022 compared to $1,160
million a year ago.
"Fourth quarter performance featured record revenues, strong
Order Bookings and continued adjusted EBIT margin expansion as core
operations and new acquisitions combined to deliver value in a
complex and volatile global environment," said Andrew Hider, Chief Executive Officer. "Our
emphasis on serving regulated industries, the size and
diversification of our Order Backlog, and the rigorous application
of the ATS Business Model by our dedicated teams position us well
for the start of our new fiscal year."
Year-to-date highlights:
- Revenues increased 52.6% year over year to $2,182.7 million.
- Net income increased 89.4% year over year to $121.4 million.
- Earnings per share was $1.32
basic and $1.31 diluted compared to
70 cents and 69 cents respectively in the prior year.
- Adjusted basic earnings per share1 were $2.17 compared to $1.07 a year ago.
- Order Bookings1 were $2,456
million, compared to $1,626
million a year ago.
Mr. Hider added "The integration of our recent acquisitions is
progressing to plan as we work to achieve cost synergies and
establish the foundation for additional organic growth through
cross selling, capability expansion and innovation. Our ability to
serve customers as a global supplier of automation, advanced
products and lifecycle support services has never been greater and
the relevance of our differentiated solutions is clear in today's
marketplace."
1 Non-IFRS
Financial Measure: see "Non-IFRS Measures and Additional IFRS
Measures".
|
Financial highlights
(In millions of dollars,
except per share and margin data)
|
Q4
2022
|
Q4 2021
|
Variance
|
Fiscal
2022
|
Fiscal 2021
|
Variance
|
Revenues
|
$
603.2
|
$ 399.9
|
50.8%
|
$ 2,182.7
|
$ 1,430.0
|
52.6%
|
Net income
|
$
39.9
|
$ 23.8
|
67.6%
|
$
121.4
|
$
64.1
|
89.4%
|
Adjusted earnings
from
operations1
|
$
85.8
|
$ 49.5
|
73.3%
|
$
292.4
|
$
163.2
|
79.2%
|
Adjusted earnings
from
operations margin1
|
14.2%
|
12.4%
|
183 bps
|
13.4%
|
11.4%
|
198 bps
|
Adjusted
EBITDA1
|
$
99.1
|
$ 58.8
|
68.54%
|
$
343.9
|
$
200.7
|
71.4%
|
Adjusted EBITDA
margin1
|
16.4%
|
14.7%
|
173 bps
|
15.8%
|
14.0%
|
172bps
|
Basic earnings per
share
|
$
0.43
|
$ 0.26
|
65.4%
|
$
1.32
|
$
0.70
|
88.6%
|
Adjusted basic earnings
per
share1
|
$
0.64
|
$ 0.34
|
88.2%
|
$
2.17
|
$
1.07
|
102.8%
|
Order
Bookings1
|
$
638.0
|
$
463.0
|
37.8%
|
$ 2,456.0
|
$ 1,626.0
|
51.0%
|
|
|
|
|
|
|
|
As at
|
|
|
|
March 31,
2022
|
March 31,
2021
|
Variance
|
Order
Backlog1
|
|
|
|
$
1,438
|
$
1,160
|
24.0%
|
1 Non-IFRS
Financial Measure: see "Non-IFRS Measures and Additional IFRS
Measures".
|
Fourth quarter summary
Fiscal 2022 fourth quarter
revenues were 50.8%, or $203.3
million higher than in the corresponding period a year ago
and included $172.1 million of
revenues earned by acquired companies, most notably $80.2 million from CFT and $59.4 million from SP. Organic revenue growth,
excluding contributions from acquired companies and the impact of
foreign exchange rate changes, was $41.8
million, or 10.5% higher than the fourth quarter of fiscal
2021. Foreign exchange translation negatively impacted revenues by
$10.6 million or 2.7%, primarily
reflecting the strengthening of the Canadian dollar relative to the
Euro. Life sciences was the primary source of organic revenue
growth and reflected increased activity on medical device and
pharmaceutical projects. Revenues generated from construction
contracts increased 37.8% or $97.5
million due to a combination of revenues earned by acquired
companies of $72.0 million (primarily
$53.0 million from CFT), and organic
revenue growth. Revenues from services increased 24.2% or
$26.6 million primarily due to
revenues earned by acquired companies of $20.7 million. Organic growth in services
accounted for $11.1 million of the
year-over-year increase and reflected the Company's after-sales
service initiatives. Foreign exchange translation negatively
impacted service revenues by $5.2
million. Revenues from the sale of goods increased 246.7% or
$79.2 million due to revenues earned
by acquired companies, primarily CFT and SP, which generate a
higher percentage of their revenues from product sales. Organic
revenue and organic revenue growth are Non-IFRS measures. Please
see "Non-IFRS and Other Financial Measures."
By market, fourth quarter revenues generated in life sciences
increased $91.6 million or 40.1% year
over year. This growth reflected higher Order Backlog entering the
fourth quarter of fiscal 2022 compared to the corresponding period
in the prior year, and included $62.1
million of revenues earned by newly acquired companies,
primarily SP, with a $40.7 million
revenue contribution. Revenues generated in food & beverage
increased $85.4 million or 871.4%,
primarily due to the acquisition of CFT, which generated
$79.9 million of revenues in the
fourth quarter of fiscal 2022. Revenues in transportation increased
$11.3 million or 16.8% on higher
Order Backlog entering the fourth quarter of fiscal 2022. Revenues
generated in consumer products increased $22.8 million or 37.9% on higher Order Backlog
entering the fourth quarter of fiscal 2022. Revenues in energy
decreased $7.8 million or 22.9% due
to project timing.
Net income for the fourth quarter of fiscal 2022 was
$39.9 million (43 cents per share basic and diluted), a
$16.1 million (or 67.6%) increase
compared to $23.8 million
(26 cents per share basic and
diluted) for the fourth quarter of fiscal 2021. This primarily
reflected an increase in earnings from operations combined with a
decrease in net finance costs. Adjusted basic earnings per share
were 64 cents compared to
34 cents in the fourth quarter of
fiscal 2021 (see "Reconciliation of Non-IFRS Measures to IFRS
Measures").
Fiscal 2022 fourth quarter earnings from operations were
$59.8 million (9.9% operating margin)
compared to $42.8 million (10.7%
operating margin) in the fourth quarter a year ago. Fiscal 2022
earnings from operations included $19.2
million related to amortization of acquisition-related
intangible assets, $1.4 million of
incremental costs related to the Company's acquisition activity,
and $1.7 million in adjustments to
contingent consideration related to the acquisition of MARCO
recorded to SG&A expenses, $5.2
million of acquisition-related inventory fair value charges
recorded to cost of revenues and $1.9
million of restructuring costs. Fiscal 2021 fourth quarter
earnings from operations included $8.1
million of amortization of acquisition-related intangible
assets, $4.2 million of incremental
costs related to the Company's acquisition activity, and
$5.6 million in adjustments to
contingent consideration related to the acquisition of MARCO.
Excluding these items in both quarters, adjusted earnings from
operations were $85.8 million (14.2%
margin), compared to $49.5 million
(12.4% margin) a year ago. Contributions from acquired companies
were $13.3 million, with SP
contributing $8.5 million and BioDot
contributing $4.3 million. Fourth
quarter fiscal 2022 adjusted earnings from operations reflected
higher gross margin due to efficiency gains made in the Company's
cost structure resulting from previously implemented
reorganizations, improved program execution, increased revenues
from after-sales services, as well as a reduction in COVID-19
travel, entry restrictions and temporary closures at customer sites
compared to a year ago.
Depreciation and amortization expense was $32.5 million in the fourth quarter of fiscal
2022, compared to $17.4 million a
year ago. The increase was primarily due to the addition of
identifiable intangible assets recorded on the acquisitions of CFT,
BioDot and SP.
EBITDA was $92.3 million (15.3%
EBITDA margin) in the fourth quarter of fiscal 2022 compared to
$60.2 million (15.1% EBITDA margin)
in the fourth quarter of fiscal 2021. EBITDA for the fourth quarter
of fiscal 2022 included $1.9 million
of restructuring charges, $1.4
million of incremental costs related to the Company's
acquisition activity, $5.2 million of
acquisition-related inventory fair value charges and $1.7 million in adjustments to contingent
consideration on the acquisition of MARCO. EBITDA for the
corresponding period in the prior year included $4.2 million of incremental costs related to the
Company's acquisition activity and $5.6
million in adjustments to contingent consideration on the
acquisition of MARCO. Excluding these costs, adjusted EBITDA was
$99.1 million (16.4% adjusted EBITDA
margin), compared to $58.8 million
(14.7% adjusted EBITDA margin) a year ago. Higher adjusted EBITDA
margin reflected operating improvements including to the Company's
cost structure and less pronounced pandemic inefficiencies than in
the same period a year ago. EBITDA margin is a Non-IFRS ratio; see
"Non-IFRS and Other Financial Measures."
Order Backlog Continuity
(In millions of dollars)
|
Q4
2022
|
Q4 2021
|
Fiscal
2022
|
Fiscal
2021
|
Opening Order
Backlog
|
$
1,475
|
$
985
|
$
1,160
|
$
942
|
Revenues
|
(603)
|
(400)
|
(2,183)
|
(1,430)
|
Order
Bookings
|
638
|
463
|
2,456
|
1,626
|
Order Backlog
adjustments1
|
(72)
|
112
|
5
|
22
|
Total
|
$
1,438
|
$
1,160
|
$
1,438
|
$ 1,160
|
1 Order
Backlog adjustments include incremental Order Backlog of acquired
companies ($104 million SP, $13 million NCC and $24 million BioDot
included in fiscal 2022), foreign exchange adjustments, scope
changes and cancellations.
|
Order Bookings
Fourth quarter fiscal 2022 Order
Bookings were $638 million, a 37.8%
year-over-year increase. This reflected organic growth of 1.0% and
39.5% growth from acquired companies, partially offset by a 2.7%
decrease due to foreign exchange rate translation of Order Bookings
by ATS' global subsidiaries, primarily reflecting the strengthening
of the Canadian dollar relative to the Euro. Growth in Order
Bookings from acquired companies totalled $182 million, of which CFT contributed
$81 million and SP contributed
$66 million. By market, Order
Bookings in life sciences increased due to the addition of SP.
Order Bookings in food & beverage increased due to the addition
of CFT. Order Bookings in consumer products increased due to the
combination of acquired companies and the timing of customer
projects. Organic growth was offset by lower Order Bookings in
transportation compared to a year ago, when the Company secured a
large EV program, and lower Order Bookings in energy due to timing
of customer projects.
Backlog
At March 31,
2022, Order Backlog was $1,438
million, 24.0% higher than at March
31, 2021. Order Backlog growth was primarily driven by
higher Order Bookings in fiscal 2022 in all end markets, and Order
Backlog from acquired businesses.
Outlook
The Company's funnel (which includes customer
requests for proposal and ATS-identified customer opportunities)
remains significant; however, as pandemic restrictions have eased
in some geographies, persistent supply constraint pressures and
inflation contribute to a fluid and uncertain operating
environment. These factors may impact the timing to convert
opportunities into Order Bookings and may present increased
pressure on future results.
By market, the life sciences funnel remains robust as a result
of strong activity in medical devices, pharmaceuticals and
radiopharmaceuticals. Funnel activity in food & beverage is
robust and with the addition of CFT, the Company has enhanced its
exposure to opportunities in this market. In transportation, the
funnel largely includes strategic opportunities related to electric
vehicles, a growing market. Funnel activity in energy is stable and
comprised of some opportunities being developed over the longer
term. Funnel activity in consumer products has improved; however,
management expects some customers to remain cautious in deploying
capital in the current economic environment. Funnel growth in
markets where environmental, social and governance ("ESG")
requirements are an increasing focus for customers, including grid
battery storage, electric vehicle ("EV") and nuclear, as well as
consumer goods packaging, provide ATS with opportunities to use its
capabilities to respond to customer sustainability standards and
goals. Customers seeking to de-risk or enhance the resiliency of
their supply chains also provide future opportunities for ATS to
pursue.
Order Backlog of $1,438 million is
expected to mitigate some of the impact of quarterly variability in
Order Bookings on revenues in the short term. The Company's Order
Backlog includes several large enterprise programs that have longer
periods of performance and therefore longer revenue recognition
cycles. In the first quarter of fiscal 2023, management expects the
conversion of Order Backlog to revenues to be in the lower end of
the 40% to 45% range. This estimate was calculated based on the
combination of management's estimate of current projects in Order
Backlog and expectations for revenues that will be booked and
recognized within the period.
The timing of customer decisions on larger opportunities is
expected to cause variability in Order Bookings from quarter to
quarter and lengthen the performance period and revenue recognition
for certain customer programs. Revenue in a given period is
dependent on a combination of the volume of outstanding projects
the Company is contracted to, the size and duration of those
projects, and the timing of project activities including design,
assembly, testing, and installation. Given the specialized nature
of the Company's offerings, the size and scope of projects vary
based on customer needs. The Company seeks to achieve revenue
growth organically and by identifying strategic acquisition
opportunities that can provide access to attractive end markets and
new products and technologies. The Company is working to grow its
product portfolio and after-sales service revenues as a percentage
of overall revenues over time, which is expected to provide some
balance to the capital expenditure cycles of the Company's
customers.
Management is pursuing several initiatives to grow its revenues
and improve its profitability with the goal of expanding its
adjusted earnings from operations margin to 15% over the long term
from 13.5% in fiscal 2022 (2021 – 11.4%). These initiatives include
growing the Company's after-sales service business, improving
global supply chain management, increasing the use of standardized
platforms and technologies, growing revenues while leveraging the
Company's cost structure, and pursuing continuous improvement in
all business activities through the ABM. The Company continues to
make progress in line with its plans to integrate businesses
acquired over the last year and expects to realize cost and revenue
synergies consistent with announced integration plans.
In the short term, the global COVID-19 pandemic has disrupted
global supply chains, leading to longer lead times and cost
increases on certain raw materials and components used by the
Company. To date the Company has largely mitigated these supply
chain disruptions through the use of alternative supply sources and
savings on materials not affected by cost increases. However,
further cost increases or prolonged disruptions could impact the
timing and progress of the Company's margin expansion efforts and
the timing of revenue recognition. Achieving management's margin
target assumes that the Company will successfully implement the
initiatives noted above, and that such initiatives will result in
improvements to its adjusted earnings from operations margin (see
"Note to Readers: Forward-Looking Statements" for a description of
the risks underlying the achievement of the margin target in future
periods).
COVID-19 resulted in governments worldwide enacting emergency
measures to combat the spread of the virus beginning in
March 2020 (just prior to the
Company's fiscal 2021 year). These measures, which included the
implementation of travel restrictions, quarantine periods and
physical distancing requirements affected economies and disrupted
business operations for ATS and its customers. While vaccination
programs are underway and generally restrictions are easing across
most countries, there is ongoing concern and uncertainty regarding
potential new variants. As a result, it remains difficult to
predict the duration or severity of the pandemic or its affect on
the business, financial results and conditions of the Company.
Furthermore, depending on the duration and severity of the COVID-19
pandemic, it may also have the effect of heightening many of the
other business risks such as risks relating to the Company's supply
chain (availability and cost of raw materials and components) and
the successful on-time completion of customer contracts.
Over the long term, the Company generally expects to continue
investing in non-cash working capital to support the growth of its
business, with fluctuations expected on a quarter-over-quarter
basis. The Company's goal is to maintain its investment in non-cash
working capital as a percentage of annualized revenues below 15%.
The Company expects that continued cash flows from operations,
together with cash and cash equivalents on hand and credit
available under operating and long-term credit facilities will be
sufficient to fund its requirements for investments in non-cash
working capital and capital assets, and fund strategic investment
plans including some potential acquisitions. Acquisitions could
result in additional debt or equity financing requirements for the
Company. Non-cash working capital as a percentage of revenues is a
Non-IFRS ratio; see "Non-IFRS and Other Financial Measures."
Quarterly Conference Call
ATS will host a conference
call and webcast at 8:30 a.m. eastern
on Thursday, May 19, 2022 to discuss
its quarterly results. The listen-only webcast can be accessed live
at www.atsautomation.com. The conference call can be accessed live
by dialing (416) 764-8659 five minutes prior. A replay of the
conference will be available on the ATS website following the call.
Alternatively, a telephone recording of the call will be available
for one week (until midnight May 26,
2022) by dialing (416) 764-8677 and entering passcode 552564
followed by the number sign.
About ATS
ATS is an industry-leading automation
solutions provider to many of the world's most successful
companies. ATS uses its extensive knowledge base and global
capabilities in custom automation, repeat automation, automation
products and value-added services including pre-automation and
after-sales services, to address the sophisticated manufacturing
automation systems and service needs of multinational customers in
markets such as life sciences, food & beverage, transportation,
consumer products, and energy. Founded in 1978, ATS employs over
6,000 people at more than 50 manufacturing facilities and over 75
offices in North America,
Europe, Southeast Asia and China.
Consolidated Revenues
(In millions of
dollars)
Revenues by
type
|
Q4
2022
|
Q4 2021
|
Fiscal
2022
|
Fiscal 2021
|
Revenues from
construction contracts
|
$
355.6
|
$
258.1
|
$ 1,359.7
|
$
895.1
|
Services
rendered
|
136.3
|
109.7
|
485.7
|
413.3
|
Sale of
goods
|
111.3
|
32.1
|
337.3
|
121.6
|
Total
revenues
|
$
603.2
|
$
399.9
|
$ 2,182.7
|
$
1,430.0
|
|
|
|
|
|
Revenues by
market
|
Q4
2022
|
Q4 2021
|
Fiscal
2022
|
Fiscal 2021
|
Life
Sciences
|
$
320.3
|
$
228.7
|
$ 1,113.0
|
$
805.4
|
Food &
Beverage
|
95.2
|
9.8
|
395.0
|
35.0
|
Transportation
|
78.6
|
67.3
|
293.8
|
272.3
|
Consumer
Products
|
82.9
|
60.1
|
269.0
|
203.2
|
Energy
|
26.2
|
34.0
|
111.9
|
114.1
|
Total
revenues
|
$
603.2
|
$
399.9
|
$ 2,182.7
|
$
1,430.0
|
|
|
|
|
|
Revenues by customer
location
|
Q4
2022
|
Q4 2021
|
Fiscal
2022
|
Fiscal 2021
|
North
America
|
$
333.3
|
$
198.5
|
$ 1,114.3
|
$
687.6
|
Europe
|
207.3
|
140.3
|
822.9
|
567.8
|
Asia/Other
|
62.6
|
61.1
|
245.5
|
174.6
|
Total
revenues
|
$
603.2
|
$
399.9
|
$ 2,182.7
|
$
1,430.0
|
Consolidated Operating Results
(In millions of
dollars)
|
Q4
2022
|
Q4 2021
|
Fiscal
2022
|
Fiscal 2021
|
Earnings from
operations
|
$
59.8
|
$
42.8
|
$
186.6
|
$
119.6
|
Amortization of
acquisition-related intangible assets
|
19.2
|
8.1
|
63.9
|
33.5
|
Acquisition-related
transaction costs
|
1.4
|
4.2
|
12.0
|
6.7
|
Acquisition-related
inventory fair value charges
|
5.2
|
––
|
25.7
|
––
|
Gain on sale of
facility
|
––
|
––
|
––
|
(5.3)
|
Contingent
consideration adjustment
|
(1.7)
|
(5.6)
|
(1.7)
|
(5.6)
|
Restructuring
charges
|
1.9
|
––
|
5.9
|
14.3
|
Adjusted earnings
from operations1
|
$
85.8
|
$
49.5
|
$
292.4
|
$
163.2
|
1Non-IFRS
Financial Measure, See "Non-IFRS and Other Financial
Measures"
|
|
Q4
2022
|
Q4 2021
|
Fiscal
2022
|
Fiscal 2021
|
Earnings from
operations
|
$
59.8
|
$
42.8
|
$
186.6
|
$
119.6
|
Depreciation and
amortization
|
32.5
|
17.4
|
115.4
|
71.0
|
EBITDA1
|
$
92.3
|
$
60.2
|
$
302.0
|
$ 190.6
|
Restructuring
charges
|
1.9
|
––
|
5.9
|
14.3
|
Acquisition-related
transaction costs
|
1.4
|
4.2
|
12.0
|
6.7
|
Acquisition-related
inventory fair value charges
|
5.2
|
––
|
25.7
|
––
|
Gain on sale of
facility
|
––
|
––
|
––
|
(5.3)
|
Contingent
consideration adjustment
|
(1.7)
|
(5.6)
|
(1.7)
|
(5.6)
|
Adjusted
EBITDA1
|
$
99.1
|
$
58.8
|
$
343.9
|
$ 200.7
|
1Non-IFRS
Financial Measure, See "Non-IFRS and Other Financial
Measures"
|
Order Backlog by Market
(In millions of dollars)
As at
|
March 31,
2022
|
March 31,
2021
|
Life
Sciences
|
$
734
|
$
585
|
Food &
Beverage
|
183
|
169
|
Transportation
|
208
|
197
|
Consumer
Products
|
211
|
113
|
Energy
|
102
|
96
|
Total
|
$
1,438
|
$
1,160
|
Reconciliation of Non-IFRS Measures to IFRS
Measures
(In millions of dollars, except per share data)
The following tables reconciles adjusted EBITDA and EBITDA to
the most directly comparable IFRS measure (net income):
|
Fiscal
2022
|
Fiscal 2021
|
Fiscal 2020
|
Adjusted
EBITDA
|
$
343.9
|
$
200.7
|
$
195.1
|
Less: restructuring
charges
|
5.9
|
14.3
|
26.6
|
Less: acquisition
related-transaction costs
|
12.0
|
6.7
|
1.5
|
Less:
acquisition-related inventory fair value charges
|
25.7
|
––
|
––
|
Add: gain on sale of
facility
|
––
|
(5.3)
|
––
|
Add: contingent
consideration adjustment
|
(1.7)
|
(5.6)
|
––
|
EBITDA
|
$
302.0
|
$
190.6
|
$
167.0
|
Less: depreciation and
amortization expense
|
115.4
|
71.0
|
71.4
|
Earnings from
operations
|
$
186.6
|
$
119.6
|
$
95.6
|
Less: net finance
costs
|
32.2
|
40.1
|
28.1
|
Less: provision for
income taxes
|
33.0
|
15.4
|
14.6
|
Net
income
|
$
121.4
|
$
64.1
|
$
52.9
|
|
Q4
2022
|
Q4 2021
|
Adjusted
EBITDA
|
$
99.1
|
$
58.8
|
Less: restructuring
charges
|
1.9
|
––
|
Less: acquisition
related-transaction costs
|
1.4
|
4.2
|
Less:
acquisition-related inventory fair value charges
|
5.2
|
––
|
Add: contingent
consideration adjustment
|
(1.7)
|
(5.6)
|
EBITDA
|
$
92.3
|
$
60.2
|
Less: depreciation and
amortization expense
|
32.5
|
17.4
|
Earnings from
operations
|
$
59.8
|
$
42.8
|
Less: net finance
costs
|
9.6
|
16.7
|
Less: provision for
income taxes
|
10.3
|
2.3
|
Net
income
|
$
39.9
|
$
23.8
|
The following table reconciles adjusted earnings from operations
and adjusted basic earnings per share to the most directly
comparable IFRS measure (net income and basic earnings per
share):
|
Three Months Ended
March 31, 2022
|
Three Months Ended
March 31, 2021
|
|
|
|
Provision
|
|
|
|
|
Provision
|
|
|
|
Earnings
|
|
for
|
|
|
Earnings
|
|
for
|
|
|
|
from
|
Finance
|
income
|
Net
|
Basic
|
from
|
Finance
|
income
|
Net
|
Basic
|
|
operations
|
costs
|
taxes
|
income
|
EPS
|
operations
|
costs
|
taxes
|
income
|
EPS
|
Reported
(IFRS)
|
$ 59.8
|
$ (9.6)
|
$
(10.3)
|
$ 39.9
|
$
0.43
|
$
42.8
|
$
(16.7)
|
$
(2.3)
|
$
23.8
|
$
0.26
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of
acquisition-
related intangibles
|
19.2
|
––
|
––
|
19.2
|
0.21
|
8.1
|
––
|
––
|
8.1
|
0.09
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring
charges
|
1.9
|
––
|
––
|
1.9
|
0.02
|
––
|
––
|
––
|
––
|
––
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition-related
fair
value inventory charges
|
5.2
|
––
|
––
|
5.2
|
0.06
|
––
|
––
|
––
|
––
|
––
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition-related
transaction costs
|
1.4
|
––
|
––
|
1.4
|
0.02
|
4.2
|
––
|
––
|
4.2
|
0.05
|
|
|
|
|
|
|
|
|
|
|
|
Contingent
consideration
adjustment
|
(1.7)
|
––
|
––
|
(1.7)
|
(0.02)
|
(5.6)
|
––
|
––
|
(5.6)
|
(0.06)
|
|
|
|
|
|
|
|
|
|
|
|
Adjustment to net
finance
costs1
|
––
|
––
|
––
|
––
|
––
|
––
|
9.1
|
––
|
9.1
|
0.10
|
|
|
|
|
|
|
|
|
|
|
|
Tax effect
adjustments2
|
––
|
––
|
(7.1)
|
(7.1)
|
(0.08)
|
––
|
––
|
(8.7)
|
(8.7)
|
(0.10)
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted
(non-IFRS)
|
$ 85.8
|
|
|
$ 58.8
|
$
0.64
|
$
49.5
|
|
|
$
30.9
|
$
0.34
|
1
Adjustments to net finance costs relate to non-recurring finance
costs associated with the redemption of the U.S. $250.0 million
6.5% senior notes that were due in 2023.
|
2 Adjustments to provision for income
taxes relate to the income tax effects of adjustment items that are
excluded for the purposes of calculating non-IFRS based adjusted
net income. For the three months ended March 31, 2021, adjustments
to provision for income taxes include $4.4 million of income tax
effects on adjustment items that are excluded for the purposes of
calculating non-IFRS based adjusted net income, and a non-recurring
provision for income taxes amount of $4.3 million primarily related
to the impact of tax planning opportunities which were implemented
in the fourth quarter of fiscal 2021.
|
|
Twelve Months Ended
March 31, 2022
|
Twelve Months Ended
March 31, 2021
|
|
|
|
Provision
|
|
|
|
|
Provision
|
|
|
|
Earnings
|
|
for
|
|
|
Earnings
|
|
for
|
|
|
|
from
|
Finance
|
income
|
Net
|
Basic
|
from
|
Finance
|
income
|
Net
|
Basic
|
|
operations
|
costs
|
taxes
|
income
|
EPS
|
operations
|
costs
|
taxes
|
income
|
EPS
|
Reported
(IFRS)
|
$
186.6
|
$
(32.2)
|
$
(33.0)
|
$
121.4
|
$
1.32
|
$
119.6
|
$
(40.1)
|
$
(15.4)
|
$
64.1
|
$
0.70
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of
acquisition-
related intangibles
|
63.9
|
––
|
––
|
63.9
|
0.69
|
33.5
|
––
|
––
|
33.5
|
0.37
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring
charges
|
5.9
|
––
|
––
|
5.9
|
0.07
|
14.3
|
––
|
––
|
14.3
|
0.16
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition-related
fair
value inventory charges
|
25.7
|
––
|
––
|
25.7
|
0.28
|
––
|
––
|
––
|
––
|
––
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition-related
transaction costs
|
12.0
|
––
|
––
|
12.0
|
0.13
|
6.7
|
––
|
––
|
6.7
|
0.07
|
|
|
|
|
|
|
|
|
|
|
|
Gain on sale of
facility
|
––
|
––
|
––
|
––
|
––
|
(5.3)
|
––
|
––
|
(5.3)
|
(0.06)
|
|
|
|
|
|
|
|
|
|
|
|
Contingent
consideration
adjustment
|
(1.7)
|
––
|
––
|
(1.7)
|
(0.02)
|
(5.6)
|
––
|
––
|
(5.6)
|
(0.06)
|
|
|
|
|
|
|
|
|
|
|
|
Adjustment to net
finance
costs1
|
––
|
––
|
––
|
––
|
––
|
––
|
9.1
|
––
|
9.1
|
0.10
|
|
|
|
|
|
|
|
|
|
|
|
Tax effect
adjustments2
|
––
|
––
|
(27.4)
|
(27.4)
|
(0.30)
|
––
|
––
|
(18.7)
|
(18.7)
|
(0.21)
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted
(non-IFRS)
|
$
292.4
|
|
|
$
199.8
|
$
2.17
|
$
163.2
|
|
|
$
98.1
|
$
1.07
|
1 Adjustments to net finance costs
relate to non-recurring finance costs associated with the
redemption of the U.S. $250.0 million 6.5% senior notes that were
due in 2023.
|
2 Adjustments to provision for income
taxes relate to the income tax effects of adjustment items that are
excluded for the purposes of calculating non-IFRS based adjusted
net income. For fiscal 2021, adjustments to provision for income
taxes included $14.4 million of income tax effects on adjustment
items that are excluded for the purposes of calculating non-IFRS
based adjusted net income, and a non-recurring provision for income
taxes amount of $4.3 million primarily related to the impact of tax
planning opportunities which were implemented in the fourth quarter
of fiscal 2021.
|
The following table reconciles organic revenue to the most
directly comparable IFRS measure (revenue):
|
Q4
2022
|
Q4 2021
|
Fiscal
2022
|
Fiscal 2021
|
Organic
revenue
|
$
441.7
|
$
402.6
|
$ 1,721.9
|
$
1,388.0
|
Revenues of acquired
companies
|
172.1
|
0.9
|
521.7
|
25.3
|
Impact of foreign
exchange rate changes
|
(10.6)
|
(3.6)
|
(60.9)
|
16.7
|
Total
revenue
|
$
603.2
|
$
399.9
|
$ 2,182.7
|
$
1,430.0
|
Organic revenue
growth
|
10.5%
|
|
20.4%
|
|
The following table reconciles non-cash working capital as a
percentage of revenues to the most directly comparable IFRS
measures:
As at
|
March 31,
2022
|
March 31,
20211
|
Accounts
receivable
|
$
348.6
|
$ 285.9
|
Income tax
receivable
|
9.0
|
8.2
|
Contract
assets
|
360.8
|
272.8
|
Inventories
|
207.9
|
138.0
|
Deposits, prepaids and
other assets
|
84.5
|
37.8
|
Accounts payable and
accrued liabilities
|
(501.5)
|
(368.9)
|
Income tax
payable
|
(48.6)
|
(31.0)
|
Contract
liabilities
|
(248.3)
|
(218.3)
|
Provisions
|
(24.8)
|
(29.0)
|
Non-cash working
capital
|
$
187.6
|
$
95.5
|
Trailing six-month
revenues annualized
|
$
2,300.0
|
$
1,539.2
|
Working capital
%
|
8.2%
|
6.2%
|
1 Certain balances as at March 31,
2021 have been re-presented as a result of measurement period
adjustments for the acquisition of CFT as required by IFRS 3,
Business Combinations. See the Annual Audited Consolidated
Financial Statements for the year ended March 31, 2022.
|
The following table reconciles net debt to adjusted EBITDA to
the most directly comparable IFRS measures:
As at
|
March 31,
2022
|
March 31,
2021
|
Cash and cash
equivalents
|
$
135.3
|
$
187.5
|
Bank
indebtedness
|
(1.8)
|
(1.1)
|
Current portion of
lease liabilities
|
(20.0)
|
(15.2)
|
Current portion of
long-term debt
|
(0.0)
|
(0.1)
|
Long-term lease
liabilities
|
(62.9)
|
(57.8)
|
Long-term
debt
|
(1,016.7)
|
(430.6)
|
Net
Debt
|
$
(966.1)
|
$
(317.3)
|
Adjusted EBITDA
(TTM)
|
$
343.9
|
$
200.7
|
Net Debt to Adjusted
EBITDA
|
2.8x
|
1.6x
|
The following table reconciles free cash flow to the most
directly comparable IFRS measures:
(in millions of
dollars)
|
Q4
2022
|
Q4 2021
|
Fiscal
2022
|
Fiscal 2021
|
Cash flows provided by
operating activities
|
$
30.0
|
$
38.9
|
$
216.2
|
$ 185.2
|
Acquisition of
property, plant and equipment
|
(8.4)
|
(10.4)
|
(36.3)
|
(21.5)
|
Acquisition of
intangible assets
|
(7.9)
|
(2.6)
|
(17.0)
|
(10.0)
|
Free cash
flow
|
$
13.7
|
$ 25.9
|
$
162.9
|
$
153.7
|
INVESTMENTS, LIQUIDITY, CASH FLOW AND FINANCIAL
RESOURCES
(In millions of dollars, except ratios)
As at
|
March 31,
2022
|
March 31,
2021
|
Cash and cash
equivalents
|
$
135.3
|
$
187.5
|
Debt-to-equity
ratio1
|
1.14:1
|
0.59:1
|
1 Debt is
calculated as bank indebtedness, long-term debt and lease
liabilities. Equity is calculated as total equity less accumulated
other comprehensive income.
|
|
Q4
2022
|
Q4 2021
|
Fiscal
2022
|
Fiscal 2021
|
Cash, beginning of
period
|
$
200.1
|
$
224.5
|
$
187.5
|
$
358.6
|
Total cash provided by
(used in):
|
|
|
|
|
Operating activities
|
30.0
|
38.9
|
216.2
|
185.2
|
Investing activities
|
(1.2)
|
(78.1)
|
(797.5)
|
(88.1)
|
Financing activities
|
(90.1)
|
6.2
|
531.5
|
(259.1)
|
Net foreign exchange
difference
|
(3.5)
|
(4.0)
|
(2.4)
|
(9.1)
|
Cash, end of
period
|
$
135.3
|
$
187.5
|
$
135.3
|
$ 187.5
|
ATS AUTOMATION TOOLING SYSTEMS
INC.
Consolidated Statements of Financial
Position
(in thousands of Canadian dollars)
As at
|
Note
|
March 31
2022
|
March 31
2021*
|
|
|
|
|
ASSETS
|
16
|
|
|
Current
assets
|
|
|
|
Cash and cash
equivalents
|
|
$
135,282
|
$
187,467
|
Accounts
receivable
|
22
|
348,631
|
285,947
|
Income tax
receivable
|
|
9,038
|
8,158
|
Contract
assets
|
22
|
360,820
|
272,847
|
Inventories
|
6
|
207,873
|
138,011
|
Deposits, prepaids and
other assets
|
7
|
84,818
|
37,807
|
|
|
1,146,462
|
930,237
|
Non-current
assets
|
|
|
|
Property, plant and
equipment
|
10
|
222,123
|
180,296
|
Right-of-use
assets
|
8
|
81,289
|
72,570
|
Other assets
|
9
|
18,631
|
5,882
|
Goodwill
|
11
|
1,024,790
|
667,016
|
Intangible
assets
|
12
|
568,180
|
282,224
|
Deferred income tax
assets
|
18
|
7,922
|
11,087
|
Investment tax credit
receivable
|
18
|
––
|
52,440
|
|
|
1,922,935
|
1,271,515
|
Total
assets
|
|
$ 3,069,397
|
$
2,201,752
|
|
|
|
|
LIABILITIES AND
EQUITY
|
|
|
|
Current
liabilities
|
|
|
|
Bank
indebtedness
|
16
|
$
1,766
|
$
1,106
|
Accounts payable and
accrued liabilities
|
|
501,465
|
368,901
|
Income tax
payable
|
|
48,617
|
30,998
|
Contract
liabilities
|
22
|
248,329
|
218,290
|
Provisions
|
14
|
24,825
|
29,034
|
Current portion of
lease liabilities
|
8
|
19,964
|
15,197
|
Current portion of
long-term debt
|
16
|
43
|
79
|
|
|
845,009
|
663,605
|
Non-current
liabilities
|
|
|
|
Employee
benefits
|
15
|
29,132
|
34,110
|
Long-term lease
liabilities
|
8
|
62,856
|
57,764
|
Long-term
debt
|
16
|
1,016,668
|
430,634
|
Deferred income tax
liabilities
|
18
|
126,114
|
78,974
|
Other long-term
liabilities
|
9
|
3,935
|
26,305
|
|
|
1,238,705
|
627,787
|
Total
liabilities
|
|
$ 2,083,714
|
$
1,291,392
|
|
|
|
|
Commitments and
contingencies
|
16, 20
|
|
|
|
|
|
|
EQUITY
|
|
|
|
Share
capital
|
17
|
$
530,241
|
$
526,446
|
Contributed
surplus
|
|
11,734
|
11,170
|
Accumulated other
comprehensive income
|
|
22,848
|
59,830
|
Retained
earnings
|
|
416,773
|
297,818
|
Equity attributable to
shareholders
|
|
981,596
|
895,264
|
Non-controlling
interests
|
|
4,087
|
15,096
|
Total
equity
|
|
985,683
|
910,360
|
Total liabilities
and equity
|
|
$ 3,069,397
|
$
2,201,752
|
|
See accompanying notes
to the consolidated financial statements.
|
|
* Certain balances as
at March 31, 2021 have been re-presented as a result of measurement
period adjustments for the acquisition of CFT S.p.A. ("CFT") as
required by IFRS 3, Business Combinations (see note 5).
|
ATS AUTOMATION TOOLING SYSTEMS
INC.
Consolidated Statements of Income
(in
thousands of Canadian dollars, except per share amounts)
Years ended March
31
|
Note
|
2022
|
2021
|
|
|
|
|
Revenues
|
|
|
|
Revenues
from construction contracts
|
|
$
1,359,695
|
$
895,086
|
Services
rendered
|
|
485,717
|
413,323
|
Sale of
goods
|
|
337,305
|
121,643
|
|
|
|
|
Total
revenues
|
21, 22
|
2,182,717
|
1,430,052
|
|
|
|
|
Operating costs and
expenses
|
|
|
|
Cost of
revenues
|
|
1,570,287
|
1,045,795
|
Selling,
general and administrative
|
|
387,108
|
236,013
|
Restructuring costs
|
14
|
5,949
|
14,355
|
Stock-based compensation
|
19
|
32,762
|
14,280
|
Earnings from
operations
|
|
186,611
|
119,609
|
Net finance
costs
|
24
|
32,200
|
40,152
|
|
|
|
|
Income before income
taxes
|
|
154,411
|
79,457
|
|
|
|
|
Income tax
expense
|
18
|
33,019
|
15,354
|
|
|
|
|
Net
income
|
|
$
121,392
|
$
64,103
|
|
|
|
|
Attributable
to
|
|
|
|
Shareholders
|
|
$
122,101
|
$ 64,092
|
Non-controlling
interests
|
|
(709)
|
11
|
|
|
$
121,392
|
$
64,103
|
|
|
|
|
Earnings per share
attributable to shareholders
|
|
|
|
Basic
|
25
|
$
1.32
|
$
0.70
|
Diluted
|
25
|
$
1.31
|
$
0.69
|
|
See accompanying notes
to the consolidated financial statements.
|
ATS AUTOMATION TOOLING SYSTEMS
INC.
Consolidated Statements of Cash Flows
(in
thousands of Canadian dollars)
Years ended March
31
|
Note
|
2022
|
2021
|
|
|
|
|
Operating
activities
|
|
|
|
Net income
|
|
$
121,392
|
$
64,103
|
Items not involving
cash
|
|
|
|
Depreciation of property, plant and equipment
|
10
|
20,917
|
14,820
|
Amortization of right-of-use assets
|
8
|
22,202
|
16,111
|
Amortization of intangible assets
|
12
|
72,302
|
39,987
|
Deferred
income taxes
|
18
|
(35,612)
|
(29,054)
|
Other
items not involving cash
|
|
27,895
|
7,282
|
Stock-based compensation
|
19
|
1,365
|
864
|
Gain on
disposal of property, plant and equipment
|
10
|
––
|
(6,505)
|
|
|
230,461
|
107,608
|
Change in non-cash
operating working capital
|
|
(14,298)
|
77,551
|
Cash flows provided
by operating activities
|
|
$
216,163
|
$
185,159
|
|
|
|
|
Investing
activities
|
|
|
|
Acquisition of
property, plant and equipment
|
10
|
$
(36,309)
|
$
(21,541)
|
Acquisition of
intangible assets
|
12
|
(16,957)
|
(10,031)
|
Business acquisitions,
net of cash acquired
|
5
|
(745,018)
|
(68,523)
|
Proceeds from disposal
of property, plant and equipment
|
10
|
817
|
11,963
|
Cash flows used in
investing activities
|
|
$
(797,467)
|
$
(88,132)
|
|
|
|
|
Financing
activities
|
|
|
|
Bank
indebtedness
|
|
$
(1,322)
|
$
(3,585)
|
Repayment of long-term
debt
|
|
(158,626)
|
(742,091)
|
Proceeds from long-term
debt
|
|
746,223
|
504,315
|
Purchase of
non-controlling interests
|
5
|
(38,187)
|
––
|
Proceeds from exercise
of stock options
|
|
2,994
|
6,111
|
Repurchase of common
shares
|
17
|
––
|
(8,662)
|
Principal lease
payments
|
|
(19,547)
|
(15,204)
|
Cash flows provided
by (used in) financing activities
|
|
$
531,535
|
$
(259,116)
|
|
|
|
|
Effect of exchange rate
changes on cash and cash equivalents
|
|
(2,416)
|
(9,089)
|
|
|
|
|
Decrease in cash and
cash equivalents
|
|
(52,185)
|
(171,178)
|
|
|
|
|
Cash and cash
equivalents, beginning of year
|
|
187,467
|
358,645
|
|
|
|
|
Cash and cash
equivalents, end of year
|
|
$
135,282
|
$
187,467
|
|
|
|
|
Supplemental
information
|
|
|
|
Cash income taxes
paid
|
|
$
24,126
|
$ 6,528
|
Cash interest
paid
|
|
$
30,797
|
$
38,428
|
|
See accompanying notes
to the consolidated financial statements.
|
Non-IFRS measures and additional IFRS
measures
Throughout this document, management uses certain
non-IFRS financial measures, non-IFRS ratios and supplementary
financial measures to evaluate the performance of the Company.
The terms "EBITDA", "organic revenue", "adjusted net income",
"adjusted earnings from operations", "adjusted EBITDA", "adjusted
basic earnings per share", and "free cash flow", are Non-IFRS
financial measures, "EBITDA margin", "adjusted operating margin",
"adjusted EBITDA margin", "organic revenue growth", "non-cash
working capital as a percentage of revenues", and "net debt to
adjusted EBITDA" are Non-IFRS ratios, and "operating margin",
"Order Bookings", "Order Backlog", and "book-to-bill ratio" are
supplementary financial measures, which do not have any
standardized meaning prescribed within IFRS and therefore may not
be comparable to similar measures presented by other companies.
Such measures should not be considered in isolation or as a
substitute for measures of performance prepared in accordance with
IFRS. In addition, management uses "earnings from operations",
which is an additional IFRS measure, to evaluate the performance of
the Company. Earnings from operations is presented on the Company's
consolidated statements of income as net income excluding income
tax expense and net finance costs. Operating margin is an
expression of the Company's earnings from operations as a
percentage of revenues. EBITDA is defined as earnings from
operations excluding depreciation and amortization. EBITDA margin
is an expression of the Company's EBITDA as a percentage of
revenues. Organic revenue is defined as revenues in the stated
period excluding revenues from acquired companies for which the
acquired company was not a part of the consolidated group in the
comparable prior period. Organic revenue growth compares the
stated period organic revenue with the reported revenue of the
comparable period. Adjusted earnings from operations is defined as
earnings from operations before items excluded from management's
internal analysis of operating results, such as amortization
expense of acquisition-related intangible assets,
acquisition-related transaction and integration costs,
restructuring charges, and certain other adjustments which would be
non-recurring in nature ("adjustment items"). Adjusted operating
margin is an expression of the Company's adjusted earnings from
operations as a percentage of revenues. Adjusted EBITDA is defined
as adjusted earnings from operations excluding depreciation and
amortization. Adjusted EBITDA margin is an expression of the
entity's adjusted EBITDA as a percentage of revenues. Adjusted
basic earnings per share is defined as adjusted net income on a
basic per share basis, where adjusted net income is defined as
adjusted earnings from operations less net finance costs and income
tax expense, plus tax effects of adjustment items and adjusted for
other significant items of a non-recurring nature. Non-cash working
capital as a percentage of revenues is defined as the sum of
accounts receivable, contract assets, inventories, deposits,
prepaids and other assets, less accounts payable, accrued
liabilities, provisions and contract liabilities divided by the
trailing two fiscal quarter revenues annualized. Free cash flow is
defined as cash provided by operating activities less property,
plant and equipment and intangible asset expenditures. Net debt to
adjusted EBITDA is the ratio of the net debt of the Company (cash
and cash equivalents less bank indebtedness, long-term debt, and
lease liabilities) to adjusted EBITDA. Order Bookings represent new
orders for the supply of automation systems, services and products
that management believes are firm. Order Backlog is the estimated
unearned portion of revenues on customer contracts that are in
process and have not been completed at the specified date.
Book-to-bill ratio is a measure of Order Bookings compared to
revenue.
Operating margin, adjusted earnings from operations, EBITDA,
EBITDA margin, adjusted EBITDA, and adjusted EBITDA margin are used
by the Company to evaluate the performance of its operations.
Management believes that earnings from operations is an important
indicator in measuring the performance of the Company's operations
on a pre-tax basis and without consideration as to how the Company
finances its operations. Management believes that organic revenue
and organic revenue growth, when considered with IFRS measures,
allow the Company to better measure the Corporation's performance
and evaluate long-term performance trends. Organic revenue growth
also facilitates easier comparisons of the Corporation's
performance with prior and future periods and relative comparisons
to its peers. Management believes that EBITDA and adjusted EBITDA
are important indicators of the Company's ability to generate
operating cash flows to fund continued investment in its
operations. Management believes that adjusted earnings from
operations, adjusted operating margin, adjusted EBITDA, adjusted
net income and adjusted basic earnings per share are important
measures to increase comparability of performance between periods.
The adjustment items used by management to arrive at these metrics
are not considered to be indicative of the business' ongoing
operating performance. Management uses the measure "non-cash
working capital as a percentage of revenues" to assess overall
liquidity. Free cash flow is used by the Company to measure cash
flow from operations after investment in property, plant and
equipment and intangible assets. Management uses net debt to
adjusted EBITDA as a measurement of leverage of the Company. Order
Bookings provide an indication of the Company's ability to secure
new orders for work during a specified period, while Order Backlog
provides a measure of the value of Order Bookings that have not
been completed at a specified point in time. Both Order Bookings
and Order Backlog are indicators of future revenues that the
Company expects to generate based on contracts that management
believes to be firm. Book to bill ratio is used to measure the
Company's ability and timeliness to convert Order Bookings into
revenues. Management believes that ATS shareholders and potential
investors in ATS use these additional IFRS measures and non-IFRS
financial measures in making investment decisions and measuring
operational results.
A reconciliation of (i) adjusted EBITDA and EBITDA to net
income, (ii) adjusted earnings from operations to earnings from
operations, (iii) adjusted net income to net income, (iv) adjusted
basic earnings per share to basic earnings per share (v) free cash
flow to its IFRS measure components and (vi) organic revenue to
revenue in each case for the three- and twelve-month periods ended
March 31, 2022 and March 31, 2021 is contained in this MD&A (see
"Reconciliation of Non-IFRS Measures to IFRS Measures"). This
MD&A also contains a reconciliation of (i) non-cash working
capital as a percentage of revenues and (ii) net debt to their IFRS
measure components, in each case at both March 31, 2022 and March
31, 2021 (see "Reconciliation of Non-IFRS Measures to IFRS
Measures"). A reconciliation of Order Bookings and Order Backlog to
total Company revenues for the three- and twelve-month periods
ended March 31, 2022 and March 31, 2021 is also contained in this MD&A
(see "Order Backlog Continuity").
Note to Readers: Forward-Looking Statements
This
news release and results of operations of ATS contains
certain statements that may constitute forward-looking information
within the meaning of applicable securities laws ("forward-looking
statements"). Forward-looking statements include all
statements that are not historical facts regarding possible events,
conditions or results of operations that ATS believes,
expects or anticipates will or may occur in the future, including,
but not limited to: the value creation strategy; the Company's
strategy to expand organically and through acquisition; the
ATS Business Model ("ABM"); potential impacts on the time to
covert opportunities into Order Bookings; various market
opportunities for ATS; the Company's Order Backlog
partially mitigating the impact of variable Order Bookings; rate of
Order Backlog conversion to revenue; the potential impact of timing
of customer decisions on Order Bookings, performance period, and
timing of revenue recognition; expected benefits with
respect to the Company's efforts to expand its services
revenues; Company's goal of expanding its adjusted earnings from
operations margin over the long term and potential impact of supply
chain disruptions and longer lead times; expectation of synergies
from integration of acquired businesses; the uncertainty and
potential impact of COVID-19 and government emergency measures;
non-cash working capital levels as a percentage of revenues;
expectation in relation to meeting liquidity and funding
requirements for investments; potential to use debt or equity
financing to support growth strategy; expected capital expenditures
for fiscal 2023; and the Company's belief with respect to the
outcome of certain lawsuits, claims and
contingencies.
Such forward-looking statements are inherently subject to
significant known and unknown risks, uncertainties and other
factors that may cause the actual results, performance or
achievements of ATS, or developments in ATS' business or in its
industry, to differ materially from the anticipated results,
performance, achievements or developments expressed or implied by
such forward-looking statements. Important risks, uncertainties and
factors that could cause actual results to differ materially from
expectations expressed in the forward-looking statements include,
but are not limited to, the duration of the COVID-19 pandemic
and its impact on the Company, its employees, customers,
suppliers and the global economy; impact of regional or global
conflicts; general market performance including capital market
conditions and availability and cost of credit; performance of the
markets that ATS serves; impact of inflation; foreign currency and
exchange risk; the relative strength of the Canadian dollar; impact
of factors such as increased pricing pressure, increased cost of
supplies and delays in relation thereto, and possible margin
compression; the regulatory and tax environment; inability to
successfully expand organically or through acquisition, due to an
inability to grow expertise, personnel, and/or facilities at
required rates or to identify, negotiate and conclude one or more
acquisitions, or to raise, through debt or equity, or otherwise
have available, required capital; that the ABM is not effective in
accomplishing its goals; that some or all of the sales funnel is
not converted to Order Bookings due to competitive factors or
failure to meet customer needs; that the market opportunities ATS
anticipates do not materialize or that ATS is unable to exploit
such opportunities; variations in the amount of Order Backlog
completed in any given quarter; timing of customer decisions
related to large enterprise programs and potential for negative
impact associated with any cancellations or non-performance in
relation thereto; that the Company is not successful in growing its
service offering or that expected benefits are not realized; that
efforts to expand adjusted earnings from operations margin over
long-term are unsuccessful, due to any number of reasons, including
less than anticipated increase in after-sales service revenues or
reduced margins attached to those revenues, inability to achieve
lower costs through supply chain management, failure to develop,
adopt internally, or have customers adopt, standardized platforms
and technologies, inability to maintain current cost structure if
revenues were to grow, and failure of ABM to impact margins; that
acquisitions made are not integrated as quickly or effectively as
planned or expected and, as a result, anticipated benefits and
synergies are not realized; non-cash working capital as a
percentage of revenues operating at a level other than as expected
due to reasons, including, the timing and nature of Order Bookings,
the timing of payment milestones and payment terms in customer
contracts, and delays in customer programs; that capital
expenditure targets are increased in the future or the Company
experiences cost increases in relation thereto; risk that the
ultimate outcome of lawsuits, claims, and contingencies give rise
to material liabilities for which no provisions have been recorded;
, and other risks and uncertainties detailed from time to time in
ATS' filings with securities regulators, including, without
limitation, the risk factors described in ATS' annual information
form for the fiscal year ended March 31,
2022, which are available on the System for Electronic
Document Analysis and Retrieval ("SEDAR") and can be accessed at
www.sedar.com. ATS has attempted to identify important factors that
could cause actual results to materially differ from current
expectations, however, there may be other factors that cause actual
results to differ materially from such expectations.
Forward-looking statements are necessarily based on a number of
estimates, factors and assumptions regarding, among others,
management's current plans, estimates, projections, beliefs and
opinions, the future performance and results of the Company's
business and operations; assumption of successful implementation of
margin improvement initiative; and general economic conditions and
global events, including the COVID-19 pandemic.
Forward-looking statements included herein are only provided to
understand management's current expectations relating to future
periods and, as such, are not appropriate for any other purpose.
Although ATS believes that the expectations reflected in such
forward-looking statements are reasonable, such statements involve
risks and uncertainties, and ATS cautions you not to place undue
reliance upon any such forward-looking statements, which speak only
as of the date they are made. ATS does not undertake any obligation
to update forward-looking statements contained herein other than as
required by law.
SOURCE ATS Automation Tooling Systems Inc.